A study of the impact of a written action plan and multi-disciplinary (respiratory specialist nurse led) intervention in preventing re-admission and improving quality of life through better disease management in patients admitted with an exacerbation
| ISRCTN | ISRCTN70191324 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN70191324 |
| Secondary identifying numbers | N0107162719 |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 21/09/2012
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Indranil Chakravorty
Scientific
Scientific
Department of Respiratory Medicine
Lister Hospital
Coreys Mill Lane
Stevenage
SG1 4AB
United Kingdom
| Phone | +44 01438 314333 ext. 5869 |
|---|---|
| indranil.chakravorty@nhs.net |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Quality of life |
| Scientific title | |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Respiratory: Asthma |
| Intervention | A randomised, controlled trial of a self-management protocol 'Action Plan' against conventional treatment, I patients who are admitted with an acute exacerbation of a COPD or a fter a visit to the OP clinic (with a history of admission within the last 6 months). All patients would undergo baseline spirometry with assessment of reversibility to salbutamol in order to diagnose COPD and exclude asthma. Patients randomised to the intervention group would receive: 1. Education about the nature of disease, risk factors, progression, pathophysiology of exacerbations and basic principles of management 2. Smoking cession 3. Nutritional assessment 4. Physiotherapy advice on the potential for exercise and pulmonary rehabilitating 5. Respiratory assessment 21/09/2012: Please note that this trial was stopped due to a lack of funding. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Salbutamol |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/04/2005 |
| Completion date | 01/03/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/04/2005 |
| Date of final enrolment | 01/03/2009 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Respiratory Medicine
Stevenage
SG1 4AB
United Kingdom
SG1 4AB
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Hertfordshire Hospitals Research and Development Consortium (UK)
No information available
NHS R&D Support Funding
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
